---
schema_version: "secwatch.filing_event.v1"
accession: "0001398733-26-000007"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:29:56.333918+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aquestive Therapeutics files February 2026 investor presentation without new financial data

## Summary
- Presentation furnished under Regulation FD; intended for meetings with institutional investors.
- Only a title slide was provided in the exhibit; no specific financial figures or guidance.
- No updates to product pipeline, revenue, or strategic initiatives were disclosed.
- Ticker AQST continues to trade on Nasdaq; corporate address unchanged.

## SEC filing metadata
- accession: 0001398733-26-000007
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/0001398733-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/aqst-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001398733-26-000007
- JSON: https://secwatch.observer/filing/0001398733-26-000007.json
- Plain text: https://secwatch.observer/filing/0001398733-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.